Table of Contents
3 ते 6 महिन्यांच्या अल्प कालावधीसाठी, तुम्ही एकतर तुमचे पैसे पार्क करू शकतालिक्विड म्युच्युअल फंड किंवा अल्ट्रा शॉर्ट टर्मडेट म्युच्युअल फंड. द्रवम्युच्युअल फंड साधारणपणे सरकारी रोख्यांमध्ये गुंतवणूक करा आणि 3 महिन्यांपर्यंतच्या ठेवींचे प्रमाणपत्र.
तथापि, जर कोणी जास्त परताव्याची जोखीम घेण्यास उत्सुक असेल तर खालील काही पर्याय पाहू शकता
खाली यादी आहेसर्वोत्तम म्युच्युअल फंड निव्वळ मालमत्ता संपली100 कोटी
आणि गेल्या 3 महिन्यांत सर्वोत्तम परतावा दिला आहे.
An Open ended Fund of Funds Scheme with the investment objective to provide returns that tracks returns provided by Birla Sun Life Gold ETF (BSL Gold ETF). Aditya Birla Sun Life Gold Fund is a Gold - Gold fund was launched on 20 Mar 12. It is a fund with Moderately High risk and has given a Below is the key information for Aditya Birla Sun Life Gold Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the Scheme is to seek to provide returns that closely correspond to returns provided by Reliance ETF Gold BeES. Nippon India Gold Savings Fund is a Gold - Gold fund was launched on 7 Mar 11. It is a fund with Moderately High risk and has given a Below is the key information for Nippon India Gold Savings Fund Returns up to 1 year are on The investment objective of the scheme is to generate returns by investing in units of Kotak Gold Exchange Traded Fund. Kotak Gold Fund is a Gold - Gold fund was launched on 25 Mar 11. It is a fund with Moderately High risk and has given a Below is the key information for Kotak Gold Fund Returns up to 1 year are on The scheme seeks to provide returns that closely correspond to returns provided by SBI - ETF Gold (Previously known as SBI GETS). SBI Gold Fund is a Gold - Gold fund was launched on 12 Sep 11. It is a fund with Moderately High risk and has given a Below is the key information for SBI Gold Fund Returns up to 1 year are on 1. Aditya Birla Sun Life Gold Fund
CAGR/Annualized
return of 7% since its launch. Return for 2023 was 14.5% , 2022 was 12.3% and 2021 was -5% . Aditya Birla Sun Life Gold Fund
Growth Launch Date 20 Mar 12 NAV (31 Oct 24) ₹23.4279 ↓ -0.10 (-0.43 %) Net Assets (Cr) ₹393 on 30 Sep 24 Category Gold - Gold AMC Birla Sun Life Asset Management Co Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.51 Sharpe Ratio 1.55 Information Ratio 0 Alpha Ratio 0 Min Investment 100 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹12,811 31 Oct 21 ₹12,040 31 Oct 22 ₹12,473 31 Oct 23 ₹14,945 31 Oct 24 ₹19,129 Returns for Aditya Birla Sun Life Gold Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 31 Oct 24 Duration Returns 1 Month 4.8% 3 Month 13.4% 6 Month 9.3% 1 Year 28% 3 Year 16.7% 5 Year 13.9% 10 Year 15 Year Since launch 7% Historical performance (Yearly) on absolute basis
Year Returns 2023 14.5% 2022 12.3% 2021 -5% 2020 26% 2019 21.3% 2018 6.8% 2017 1.6% 2016 11.5% 2015 -7.2% 2014 -9.4% Fund Manager information for Aditya Birla Sun Life Gold Fund
Name Since Tenure Haresh Mehta 28 Apr 23 1.43 Yr. Data below for Aditya Birla Sun Life Gold Fund as on 30 Sep 24
Asset Allocation
Asset Class Value Cash 2.63% Other 97.37% Top Securities Holdings / Portfolio
Name Holding Value Quantity Aditya BSL Gold ETF
- | -99% ₹390 Cr 57,882,587
↑ 1,200,000 Clearing Corporation Of India Limited
CBLO/Reverse Repo | -2% ₹6 Cr Net Receivables / (Payables)
Net Current Assets | -1% -₹3 Cr 2. SBI Healthcare Opportunities Fund
CAGR/Annualized
return of 16.1% since its launch. Ranked 34 in Sectoral
category. Return for 2023 was 38.2% , 2022 was -6% and 2021 was 20.1% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (31 Oct 24) ₹423.835 ↑ 6.20 (1.48 %) Net Assets (Cr) ₹3,346 on 30 Sep 24 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 2.5 Information Ratio 0.4 Alpha Ratio 1.15 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹15,024 31 Oct 21 ₹19,094 31 Oct 22 ₹19,411 31 Oct 23 ₹23,158 31 Oct 24 ₹36,478 Returns for SBI Healthcare Opportunities Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 31 Oct 24 Duration Returns 1 Month 1% 3 Month 10.7% 6 Month 22.3% 1 Year 57.5% 3 Year 24.1% 5 Year 29.5% 10 Year 15 Year Since launch 16.1% Historical performance (Yearly) on absolute basis
Year Returns 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% 2014 56.8% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.35 Yr. Pradeep Kesavan 31 Dec 23 0.75 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Sep 24
Equity Sector Allocation
Sector Value Health Care 89.61% Basic Materials 6.63% Asset Allocation
Asset Class Value Cash 3.76% Equity 96.24% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA13% ₹424 Cr 2,200,000
↑ 100,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹197 Cr 2,000,000
↓ -21,773 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB6% ₹196 Cr 360,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002575% ₹175 Cr 800,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹165 Cr 1,000,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY5% ₹159 Cr 300,000 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED4% ₹148 Cr 640,000
↑ 1,703 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433084% ₹139 Cr 2,500,000 Aether Industries Ltd (Basic Materials)
Equity, Since 31 May 22 | 5435344% ₹130 Cr 1,400,000 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL4% ₹127 Cr 900,000 3. Nippon India Gold Savings Fund
CAGR/Annualized
return of 8.5% since its launch. Return for 2023 was 14.3% , 2022 was 12.3% and 2021 was -5.5% . Nippon India Gold Savings Fund
Growth Launch Date 7 Mar 11 NAV (04 Nov 24) ₹30.56 ↓ -0.42 (-1.35 %) Net Assets (Cr) ₹2,038 on 30 Sep 24 Category Gold - Gold AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk Moderately High Expense Ratio 0.34 Sharpe Ratio 1.57 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (2%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹12,974 31 Oct 21 ₹12,105 31 Oct 22 ₹12,556 31 Oct 23 ₹15,070 31 Oct 24 ₹19,303 Returns for Nippon India Gold Savings Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 31 Oct 24 Duration Returns 1 Month 3.1% 3 Month 10.5% 6 Month 9% 1 Year 27% 3 Year 16.7% 5 Year 13.7% 10 Year 15 Year Since launch 8.5% Historical performance (Yearly) on absolute basis
Year Returns 2023 14.3% 2022 12.3% 2021 -5.5% 2020 26.6% 2019 22.5% 2018 6% 2017 1.7% 2016 11.6% 2015 -8.1% 2014 -9.8% Fund Manager information for Nippon India Gold Savings Fund
Name Since Tenure Himanshu Mange 23 Dec 23 0.77 Yr. Data below for Nippon India Gold Savings Fund as on 30 Sep 24
Asset Allocation
Asset Class Value Cash 1.37% Other 98.63% Top Securities Holdings / Portfolio
Name Holding Value Quantity Nippon India ETF Gold BeES
- | -100% ₹2,038 Cr 320,686,292
↑ 6,480,000 Net Current Assets
Net Current Assets | -0% -₹7 Cr Triparty Repo
CBLO/Reverse Repo | -0% ₹7 Cr Cash Margin - Ccil
CBLO | -0% ₹0 Cr 4. Kotak Gold Fund
CAGR/Annualized
return of 8.6% since its launch. Return for 2023 was 13.9% , 2022 was 11.7% and 2021 was -4.7% . Kotak Gold Fund
Growth Launch Date 25 Mar 11 NAV (04 Nov 24) ₹30.6738 ↓ -0.41 (-1.31 %) Net Assets (Cr) ₹2,123 on 30 Sep 24 Category Gold - Gold AMC Kotak Mahindra Asset Management Co Ltd Rating ☆ Risk Moderately High Expense Ratio 0.5 Sharpe Ratio 1.57 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-6 Months (2%),6-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹13,038 31 Oct 21 ₹12,223 31 Oct 22 ₹12,628 31 Oct 23 ₹15,108 31 Oct 24 ₹19,295 Returns for Kotak Gold Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 31 Oct 24 Duration Returns 1 Month 3.1% 3 Month 10.5% 6 Month 8.9% 1 Year 26.5% 3 Year 16.2% 5 Year 13.6% 10 Year 15 Year Since launch 8.6% Historical performance (Yearly) on absolute basis
Year Returns 2023 13.9% 2022 11.7% 2021 -4.7% 2020 26.6% 2019 24.1% 2018 7.3% 2017 2.5% 2016 10.2% 2015 -8.4% 2014 -10% Fund Manager information for Kotak Gold Fund
Name Since Tenure Abhishek Bisen 25 Mar 11 13.53 Yr. Jeetu Sonar 1 Oct 22 2 Yr. Data below for Kotak Gold Fund as on 30 Sep 24
Asset Allocation
Asset Class Value Cash 2.37% Equity 1.57% Other 96.05% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kotak Gold ETF
- | -100% ₹2,115 Cr 330,692,829
↑ 8,616,547 Triparty Repo
CBLO/Reverse Repo | -1% ₹15 Cr Net Current Assets/(Liabilities)
Net Current Assets | -0% -₹7 Cr 5. SBI Gold Fund
CAGR/Annualized
return of 6.7% since its launch. Return for 2023 was 14.1% , 2022 was 12.6% and 2021 was -5.7% . SBI Gold Fund
Growth Launch Date 12 Sep 11 NAV (04 Nov 24) ₹23.3162 ↓ -0.29 (-1.24 %) Net Assets (Cr) ₹2,245 on 30 Sep 24 Category Gold - Gold AMC SBI Funds Management Private Limited Rating ☆☆ Risk Moderately High Expense Ratio 0.29 Sharpe Ratio 1.58 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹13,066 31 Oct 21 ₹12,180 31 Oct 22 ₹12,679 31 Oct 23 ₹15,233 31 Oct 24 ₹19,540 Returns for SBI Gold Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 31 Oct 24 Duration Returns 1 Month 3.2% 3 Month 10.4% 6 Month 8.6% 1 Year 27.1% 3 Year 17% 5 Year 13.9% 10 Year 15 Year Since launch 6.7% Historical performance (Yearly) on absolute basis
Year Returns 2023 14.1% 2022 12.6% 2021 -5.7% 2020 27.4% 2019 22.8% 2018 6.4% 2017 3.5% 2016 10% 2015 -8.1% 2014 -10.2% Fund Manager information for SBI Gold Fund
Name Since Tenure Raviprakash Sharma 12 Sep 11 13.06 Yr. Data below for SBI Gold Fund as on 30 Sep 24
Asset Allocation
Asset Class Value Cash 1.39% Other 98.61% Top Securities Holdings / Portfolio
Name Holding Value Quantity SBI Gold ETF
- | -100% ₹2,248 Cr 342,896,520
↑ 18,787,350 Net Receivable / Payable
CBLO | -1% -₹12 Cr Treps
CBLO/Reverse Repo | -0% ₹9 Cr
निव्वळ मालमत्ता संपलेल्या सर्वोत्तम म्युच्युअल फंडांची यादी खाली दिली आहे100 कोटी
आणि गेल्या 6 महिन्यांत सर्वोत्तम परतावा दिला आहे.
(Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Midcap 30 Fund is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on "The primary investment objective of the Scheme is to seek capital appreciation by investing predominantly in units of MLIIF - WGF. The Scheme may, at the discretion of the Investment Manager, also invest in the units of other similar overseas mutual fund schemes, which may constitute a significant part of its corpus. The Scheme may also invest a certain portion of its corpus in money market securities and/or units of money market/liquid schemes of DSP Merrill Lynch Mutual Fund, in order to meet liquidity requirements from time to time. However, there is no assurance that the investment objective of the Scheme will be realized." DSP BlackRock World Gold Fund is a Equity - Global fund was launched on 14 Sep 07. It is a fund with High risk and has given a Below is the key information for DSP BlackRock World Gold Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in Information Technology Sector in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA Digital India Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA Digital India Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on 1. UTI Healthcare Fund
CAGR/Annualized
return of 15.4% since its launch. Ranked 40 in Sectoral
category. Return for 2023 was 38.2% , 2022 was -12.3% and 2021 was 19.1% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (04 Nov 24) ₹284.107 ↓ -1.03 (-0.36 %) Net Assets (Cr) ₹1,201 on 30 Sep 24 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 2.51 Information Ratio -0.21 Alpha Ratio 1.27 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹15,449 31 Oct 21 ₹19,772 31 Oct 22 ₹18,618 31 Oct 23 ₹21,719 31 Oct 24 ₹34,592 Returns for UTI Healthcare Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 4 Nov 24 Duration Returns 1 Month -1% 3 Month 7.8% 6 Month 26% 1 Year 56.4% 3 Year 20.1% 5 Year 28.1% 10 Year 15 Year Since launch 15.4% Historical performance (Yearly) on absolute basis
Year Returns 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% 2014 43.7% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 2.42 Yr. Data below for UTI Healthcare Fund as on 30 Sep 24
Equity Sector Allocation
Sector Value Health Care 94.08% Basic Materials 1.3% Financial Services 1.24% Asset Allocation
Asset Class Value Cash 3.26% Equity 96.63% Debt 0.11% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA12% ₹142 Cr 735,274 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000876% ₹74 Cr 450,000
↓ -19,180 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323315% ₹64 Cr 200,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹59 Cr 87,100 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹47 Cr 64,796 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322963% ₹42 Cr 250,331 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL3% ₹40 Cr 74,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹39 Cr 634,445 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERIS3% ₹37 Cr 275,361
↓ -22,385 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA3% ₹37 Cr 250,000 2. Motilal Oswal Midcap 30 Fund
CAGR/Annualized
return of 24.4% since its launch. Ranked 27 in Mid Cap
category. Return for 2023 was 41.7% , 2022 was 10.7% and 2021 was 55.8% . Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (04 Nov 24) ₹102.891 ↓ -0.08 (-0.07 %) Net Assets (Cr) ₹18,604 on 30 Sep 24 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.66 Sharpe Ratio 3.44 Information Ratio 1.23 Alpha Ratio 22.5 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹9,551 31 Oct 21 ₹16,394 31 Oct 22 ₹19,861 31 Oct 23 ₹23,514 31 Oct 24 ₹39,059 Returns for Motilal Oswal Midcap 30 Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 4 Nov 24 Duration Returns 1 Month -2.8% 3 Month 3.6% 6 Month 24.5% 1 Year 63.1% 3 Year 32% 5 Year 31.6% 10 Year 15 Year Since launch 24.4% Historical performance (Yearly) on absolute basis
Year Returns 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% 2014 Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0 Yr. Niket Shah 1 Jul 20 4.25 Yr. Santosh Singh 1 Oct 24 0 Yr. Rakesh Shetty 22 Nov 22 1.86 Yr. Sunil Sawant 1 Jul 24 0.25 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 30 Sep 24
Equity Sector Allocation
Sector Value Industrials 22.85% Technology 20.91% Consumer Cyclical 17.5% Financial Services 8.81% Health Care 4.47% Basic Materials 3.7% Real Estate 2.73% Asset Allocation
Asset Class Value Cash 19.02% Equity 80.98% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL10% ₹1,855 Cr 25,400,000
↑ 400,000 Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB10% ₹1,774 Cr 2,550,000
↑ 450,000 Jio Financial Services Ltd (Financial Services)
Equity, Since 31 Aug 23 | JIOFIN9% ₹1,640 Cr 46,773,159
↑ 13,873,159 Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE8% ₹1,579 Cr 2,250,000
↑ 650,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT8% ₹1,472 Cr 2,700,000
↓ -13,800 Tube Investments of India Ltd Ordinary Shares (Industrials)
Equity, Since 31 Jul 20 | TIINDIA6% ₹1,070 Cr 2,467,811
↑ 217,811 Voltas Ltd (Industrials)
Equity, Since 31 Oct 17 | VOLTAS5% ₹923 Cr 5,000,000 Balkrishna Industries Ltd (Consumer Cyclical)
Equity, Since 28 Feb 23 | BALKRISIND4% ₹717 Cr 2,350,000
↑ 124,002 Zomato Ltd (Consumer Cyclical)
Equity, Since 30 Apr 23 | 5433204% ₹683 Cr 25,000,000
↓ -500,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | MAXHEALTH3% ₹540 Cr 5,481,171
↑ 981,171 3. DSP BlackRock World Gold Fund
CAGR/Annualized
return of 4.9% since its launch. Ranked 11 in Global
category. Return for 2023 was 7% , 2022 was -7.7% and 2021 was -9% . DSP BlackRock World Gold Fund
Growth Launch Date 14 Sep 07 NAV (31 Oct 24) ₹22.8193 ↓ -0.59 (-2.53 %) Net Assets (Cr) ₹1,098 on 30 Sep 24 Category Equity - Global AMC DSP BlackRock Invmt Managers Pvt. Ltd. Rating ☆☆☆ Risk High Expense Ratio 1.35 Sharpe Ratio 1.33 Information Ratio -0.55 Alpha Ratio -2.56 Min Investment 1,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹14,050 31 Oct 21 ₹12,675 31 Oct 22 ₹9,745 31 Oct 23 ₹11,513 31 Oct 24 ₹16,462 Returns for DSP BlackRock World Gold Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 4 Nov 24 Duration Returns 1 Month 1.9% 3 Month 10.4% 6 Month 23% 1 Year 43% 3 Year 9.1% 5 Year 10.5% 10 Year 15 Year Since launch 4.9% Historical performance (Yearly) on absolute basis
Year Returns 2023 7% 2022 -7.7% 2021 -9% 2020 31.4% 2019 35.1% 2018 -10.7% 2017 -4% 2016 52.7% 2015 -18.5% 2014 -3% Fund Manager information for DSP BlackRock World Gold Fund
Name Since Tenure Jay Kothari 1 Mar 13 11.59 Yr. Data below for DSP BlackRock World Gold Fund as on 30 Sep 24
Equity Sector Allocation
Sector Value Basic Materials 93.52% Asset Allocation
Asset Class Value Cash 2.46% Equity 93.9% Debt 0% Other 3.65% Top Securities Holdings / Portfolio
Name Holding Value Quantity BGF World Gold I2
Investment Fund | -80% ₹880 Cr 2,045,778
↓ -30,051 VanEck Gold Miners ETF
- | GDX17% ₹191 Cr 573,719 Treps / Reverse Repo Investments
CBLO/Reverse Repo | -3% ₹30 Cr Net Receivables/Payables
Net Current Assets | -0% -₹4 Cr 4. TATA Digital India Fund
CAGR/Annualized
return of 20.1% since its launch. Return for 2023 was 31.9% , 2022 was -23.3% and 2021 was 74.4% . TATA Digital India Fund
Growth Launch Date 28 Dec 15 NAV (04 Nov 24) ₹50.6724 ↑ 0.17 (0.33 %) Net Assets (Cr) ₹12,052 on 30 Sep 24 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 1.66 Information Ratio 0.81 Alpha Ratio 10.81 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹13,379 31 Oct 21 ₹24,791 31 Oct 22 ₹21,368 31 Oct 23 ₹23,581 31 Oct 24 ₹33,817 Returns for TATA Digital India Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 4 Nov 24 Duration Returns 1 Month -2.4% 3 Month 2.8% 6 Month 22.7% 1 Year 41.5% 3 Year 10.4% 5 Year 27.6% 10 Year 15 Year Since launch 20.1% Historical performance (Yearly) on absolute basis
Year Returns 2023 31.9% 2022 -23.3% 2021 74.4% 2020 54.8% 2019 7.5% 2018 24.9% 2017 19.6% 2016 -6% 2015 2014 Fund Manager information for TATA Digital India Fund
Name Since Tenure Meeta Shetty 9 Mar 21 3.56 Yr. Kapil Malhotra 19 Dec 23 0.78 Yr. Data below for TATA Digital India Fund as on 30 Sep 24
Equity Sector Allocation
Sector Value Technology 73.64% Consumer Cyclical 7.29% Industrials 6.07% Communication Services 4.72% Financial Services 3.05% Asset Allocation
Asset Class Value Cash 5.22% Equity 94.78% Top Securities Holdings / Portfolio
Name Holding Value Quantity Infosys Ltd (Technology)
Equity, Since 31 Jan 16 | INFY18% ₹2,163 Cr 11,530,857
↓ -1,719,741 Tech Mahindra Ltd (Technology)
Equity, Since 30 Apr 16 | 5327559% ₹1,127 Cr 7,145,933 Tata Consultancy Services Ltd (Technology)
Equity, Since 31 Jan 16 | TCS9% ₹1,124 Cr 2,633,873
↓ -300,000 HCL Technologies Ltd (Technology)
Equity, Since 31 Jan 16 | HCLTECH7% ₹895 Cr 4,983,886 Wipro Ltd (Technology)
Equity, Since 31 Jul 18 | 5076857% ₹825 Cr 15,243,662
↑ 3,852,046 Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Oct 22 | 5433207% ₹794 Cr 29,067,000 LTIMindtree Ltd (Technology)
Equity, Since 28 Feb 21 | LTIM5% ₹617 Cr 988,062
↓ -200,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 16 | PERSISTENT3% ₹414 Cr 759,192 Firstsource Solutions Ltd (Technology)
Equity, Since 30 Nov 21 | FSL3% ₹315 Cr 10,123,112 Cyient Ltd (Industrials)
Equity, Since 28 Feb 21 | CYIENT3% ₹307 Cr 1,630,043 5. SBI Healthcare Opportunities Fund
CAGR/Annualized
return of 16.1% since its launch. Ranked 34 in Sectoral
category. Return for 2023 was 38.2% , 2022 was -6% and 2021 was 20.1% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (31 Oct 24) ₹423.835 ↑ 6.20 (1.48 %) Net Assets (Cr) ₹3,346 on 30 Sep 24 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 2.5 Information Ratio 0.4 Alpha Ratio 1.15 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹15,024 31 Oct 21 ₹19,094 31 Oct 22 ₹19,411 31 Oct 23 ₹23,158 31 Oct 24 ₹36,478 Returns for SBI Healthcare Opportunities Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 4 Nov 24 Duration Returns 1 Month 1% 3 Month 10.7% 6 Month 22.3% 1 Year 57.5% 3 Year 24.1% 5 Year 29.5% 10 Year 15 Year Since launch 16.1% Historical performance (Yearly) on absolute basis
Year Returns 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% 2014 56.8% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.35 Yr. Pradeep Kesavan 31 Dec 23 0.75 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Sep 24
Equity Sector Allocation
Sector Value Health Care 89.61% Basic Materials 6.63% Asset Allocation
Asset Class Value Cash 3.76% Equity 96.24% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA13% ₹424 Cr 2,200,000
↑ 100,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹197 Cr 2,000,000
↓ -21,773 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB6% ₹196 Cr 360,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002575% ₹175 Cr 800,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹165 Cr 1,000,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY5% ₹159 Cr 300,000 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED4% ₹148 Cr 640,000
↑ 1,703 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433084% ₹139 Cr 2,500,000 Aether Industries Ltd (Basic Materials)
Equity, Since 31 May 22 | 5435344% ₹130 Cr 1,400,000 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL4% ₹127 Cr 900,000
Fincash.com वर आजीवन मोफत गुंतवणूक खाते उघडा.
तुमची नोंदणी आणि KYC प्रक्रिया पूर्ण करा
दस्तऐवज अपलोड करा (PAN, आधार इ.).आणि, तुम्ही गुंतवणूक करण्यास तयार आहात!